Form4insider filings, from the source

SEC Form 4 · accession 0001470831-26-000504

C4 Therapeutics, Inc. · CCCC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 1, 2026
Accepted (ET)
Jun 4, 2026 · 4:14 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001662579

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 1, 2026M1,070$2.11A69,300D
Common StockF2holding———129,877IBy Kenneth C. Anderson 2021 Irrevocable Trust
Common StockF3holding———74,581IBy Kenneth C. Anderson 2015 Irrevocable Trust
Common StockF4holding———74,581IBy Cynthia E. Anderson 2015 Irrevocable Trust
Common StockF5holding———3,623IBy Kenneth C. Anderson Revocable Trust
Common StockF6holding———3,623IBy Cynthia E. Anderson Revocable Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F7$2.11Jun 1, 2026M1,070D—Jul 12, 2026Common Stock1,0700D

Explanation of responses